Lake Street Capital Markets has named John Baumgartner as its head of capital markets, responsible for overseeing marketing, pricing, and distribution of its capital raising activities. Mr. Baumgartner began his career...
IDEAYA Biosciences (NASDAQ:IDYA) promoted Paul Stone to CFO, Andres Briseno to VP finance, and Mick O’Quigley to VP development operations. Continuing his role as IDEAYA’s principal financial and accounting...
Zenabis Global’s (TSX:ZENA) expansion in Stellarton, Nova Scotia, is good news for local residents, as the company is looking to fill several positions at that particular facility this summer.
Arcus Biosciences (NYSE:RCUS) appointed Eric Hoefer as its chief commercial officer to oversee the company’s global commercial strategy and operations.
Raymond James named finance professional, Andrew Gitkin, as managing director and co-head of the firm’s health care investment banking practice, along side managing director, Riley Sweat.
Spectrum Therapeutics, the medical division of Canopy Growth (TSX:WEED; NYSE:CGC) appointed Dr. Marcel Bonn-Miller as global clinical scientific director.